<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180627040251N21</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-08-04</date_registration>
      <primary_sponsor>Kharazmi University</primary_sponsor>
      <public_title>Comparison of the Effects of Corrective Exercises and Neuromuscular Exercises on Lower Limb Function and Muscle Activity in Young Volleyball Players Following ACL Reconstruction</public_title>
      <acronym></acronym>
      <scientific_title>Effects of National Academy of Sports Medicine (NASM)-Based Corrective Exercises and Knee-Focused Neuromuscular Training on Return-to-Sport Tests and Lower Limb Muscle Electrical Activity in Young Volleyball Players Following Anterior Cruciate Ligament Reconstruction</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-11</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/92083</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: In this study, simple randomization was used to assign participants to three groups (two intervention groups and one control group). The randomization sequence was generated using SPSS statistical software and sealed envelopes were used to ensure allocation concealment. Thus, there was no bias or side effects in the group allocation process. How to create a random sequence: A list of numbers from 1 to 45 (the total number of participants) is prepared. Using a randomization tool (such as random.org or a random number table), each number is completely randomly assigned to one of three groups (A: intervention 1, B: intervention 2, C: control). Result: A random sequence such as [A, C, B, A, B, C, ...] up to 45 people. How subjects are entered: Participants are entered in the order they register (first, second, etc.). Each person is assigned based on their position in the sequence (e.g., person 1 to A, person 2 to C, etc.). To ensure concealment, the sequence is placed in sealed envelopes and opened sequentially, Blinding description: In this study, the outcome assessor is blind to the groups’ randomization and interventions receiving by participants. in this way, during the evaluation before and after the intervention protocol, they do not make mistakes in their judgments in favor of a specific therapeutic intervention.</study_design>
      <phase>N/A</phase>
      <hc_freetext>anterior cruciate ligament Injury.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: The National Academy of Sports Medicine (NASM) training group participated in an 8‑week program, with three sessions per week. Each session included foam rolling for muscle inhibition, static and dynamic stretching, isolated strengthening of underactive muscles using resistance exercises, and full‑body functional movements to coordinate movement patterns. Intervention 2: Intervention group: The knee‑focused neuromuscular training program was conducted for 8 weeks, with three sessions per week. The emphasis was on dynamic joint stabilization, anticipatory muscle activation, and reactive motor control. Each session included a dynamic warm‑up, balance and perturbation exercises on stable and unstable surfaces, plyometric and landing retraining with visual and verbal feedback, and agility drills involving directional changes and responses to stimuli. Intervention 3: Control group: This group did not receive any training or intervention during the study period.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is It will be sent if requested</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hassan Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mirdamad - Shahid Hesari St. - Shahid Keshvari Complex - Faculty of Physical Education and Sports Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15719-14911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>hassan.sadeghi81@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Hassan Sadeghi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Mirdamad - Shahid Hesari St. - Shahid Keshvari Complex - Faculty of Physical Education and Sports Sciences</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>15719-14911</zip>
        <telephone>+98 21 2222 8001</telephone>
        <email>hassan.sadeghi81@yahoo.com</email>
        <affiliation>Kharazmi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Being male and within the age range of 18 to 30 years
Having a history of unilateral anterior cruciate ligament (ACL) reconstruction using the standard surgical technique.
At least 6 months and at most 24 months having passed since the anterior cruciate ligament reconstruction surgery.
Completion of the initial phase of medical rehabilitation and receiving clearance from a specialist physician to participate in sports activities.
Absence of severe pain, acute inflammation, or significant range of motion limitation at the time of testing.
Ability to perform single‑leg landing tasks and return‑to‑sport tests without severe pain or a strong feeling of instability.
Having adequate functional range of motion of the knee joint, particularly full functional flexion and extension.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>30 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Bilateral ACL reconstruction or a history of ACL rupture in the contralateral limb; or meniscal tear requiring recent intervention.
History of other knee surgery within the past 6 months; recent arthroscopy; or active pain/swelling that prevents participation in exercises.
Neurological, cardiovascular, or metabolic diseases that affect exercise performance (as diagnosed by a physician).
Active knee instability on clinical examination, or severe kinesiophobia that makes task performance impossible.
Use of medications affecting neuromuscular function that cause rapid changes.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>S83.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Sprain of cruciate ligament of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: The National Academy of Sports Medicine (NASM) training group participated in an 8‑week program, with three sessions per week. Each session included foam rolling for muscle inhibition, static and dynamic stretching, isolated strengthening of underactive muscles using resistance exercises, and full‑body functional movements to coordinate movement patterns</i_keyword>
      <i_keyword>Intervention group: The knee‑focused neuromuscular training program was conducted for 8 weeks, with three sessions per week. The emphasis was on dynamic joint stabilization, anticipatory muscle activation, and reactive motor control. Each session included a dynamic warm‑up, balance and perturbation exercises on stable and unstable surfaces, plyometric and landing retraining with visual and verbal feedback, and agility drills involving directional changes and responses to stimuli</i_keyword>
      <i_keyword>Control group: This group did not receive any training or intervention during the study period.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Lower limb muscle Electromyography. Timepoint: Beginning and end of exercises duration. Method of measurement: Electromyography device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Return‑to‑sport functional tests. Timepoint: Before and after exercise protocols. Method of measurement: Single leg hop for distance, Crossover hop for distance, 6‑m timed hop ,Triple hop for distance.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Kharazmi University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-06-20</approval_date>
        <contact_name>Ethical Committee of Kharazmi University-Iran</contact_name>
        <contact_address>Enghlab- Mofateh St. Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
